Skip To Main Content
Pouria Delbari on Muck Rack

Pouria Delbari

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Pouria

Contact Pouria, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Single-fraction versus multifraction stereotactic radiosurgery for spinal metastases: systematic review and meta-analysis

|
By Pouria Delbari, Muhammad Hussain Ahmadvand, Raha Zamani, Amirmasoud Karimi
| Journal of Neurosurgery Verified
Keywords: spinal metastases; stereotactic radiosurgery; single fraction; multifraction; local control Spinal metastases are a common and devastating complication of cancer, affecting up to 40% of cancer patients and significantly diminishing their quality of life.1,2 Brain and spine lesion management has evolved substantially with the advent of radiosurgery techniques.3,4 Stereotactic radiosurgery (SRS) has become a highly effective and minimally invasive treatment for spinal metastases by...
Open in Who Shared Issue with article?

The clinical utility of autologous tumor lysate‐loaded dendritic cell vaccination for patients with glioma: A systematic review and meta‐analysis

|
By Mohammad Amin Habibi, Mohammad Sina Mirjani, Muhammad Hussain Ahmadvand, Pouria Delbari
| Wiley Online Library Verified
CI confidence interval CR complete response rate DC dendritic cell GBM glioblastoma MOS median overall survival ORR overall response rate PD progressive disease rate PFS progression-free survival PR partial response rate SD stable disease 1 INTRODUCTION Dendritic cell (DC) vaccines loaded with tumor lysates have emerged as a promising immunotherapy approach for patients with malignant gliomas.
Open in Who Shared Issue with article?
See all 2 articles